Skip to main content

Table 2 Overall survival multivariate analysis

From: CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers

  Cohort A Cohort B
HR CI 95% P value HR CI 95% P value
MMP-9 in CD68 1.26 0.20–10.35 0.81    0.2
MMP-9 in CD163 0.46 0.07–2.23 0.35 1.99 0.27–13.44 0.47
CD163 1.71 0.88–3.5 0.11 0.45 0.08–2.25 0.33
CD68 1.58 0.66–4.02 0.3 13.44 0.76–382.29 0.07
Age >50 years 6.24 2.13–20.21 0.0006 2.6 0.27–58.1 0.41
Size >2 cm 1.14 0.49–2.69 0.75 3.4 0.11–103 0.42
Grade 1.67 0.87–3.16 0.11 0.41 0.03–9.36 0.51
  1. Abbreviations: CI confidence interval, HR hazard ratio, MMP-9 matrix metalloproteinase 9